Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 224

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 16A
Chunk 224
---
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

Our Audit Committee is currently comprised of
Oz Adler, Yehonatan Shachar and Assaf Ithaki, and is chaired by Oz Adler. Our Board has determined that each of the members of the committee
are financially literate and meets the independence requirements for directors, including the heightened independence standards for members
of the Audit Committee under Rule 10A-3 under the Exchange Act and NI 52-110. Our Board has determined that Oz Adler is “financially
sophisticated” within the meaning of the Nasdaq Rules, “financially literate” within the meaning of NI 52-110, and
a “financial expert” as defined by Rule 10A-3 under the Exchange Act.

ITEM 16B. CODE OF ETHICS